111 Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

111 heeft een totaal eigen vermogen van CN¥246.7M en een totale schuld van CN¥189.4M, wat de schuld-eigenvermogensverhouding op 76.7% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥2.8B en CN¥2.5B.

Belangrijke informatie

76.7%

Verhouding schuld/eigen vermogen

CN¥189.37m

Schuld

Rente dekkingsratio	n/a
Contant	CN¥595.45m
Aandelen	CN¥246.73m
Totaal verplichtingen	CN¥2.54b
Totaal activa	CN¥2.79b

Recente financiële gezondheidsupdates

Recent updates

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

Sep 10

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

Aug 25

111, Inc.'s Inexorable Drive Towards Profitability

Jul 27

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

Sep 16

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

Aug 25

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

Aug 18

Is 111 (NASDAQ:YI) A Risky Investment?

Apr 09

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

Mar 05

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

Jan 29

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Dec 25

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Dec 04

111 reports Q3 results, provides Q4 revenue guidance

Nov 19

111, Inc.: Cheap But Risky And Controlled By Founders

Nov 16

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥2.7B ) YI } overtreffen de korte termijn passiva ( CN¥2.5B ).

Langlopende schulden: De kortetermijnactiva YI ( CN¥2.7B ) overtreffen de langetermijnschulden ( CN¥63.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: YI heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van YI is de afgelopen 5 jaar gestegen van 3.6% naar 76.7%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Terwijl het verlieslatende YI voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.

Voorspelling contante baan: YI is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, omdat de vrije kasstroom positief is en met 6.7 % per jaar groeit.

111 Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. announced delayed 20-F filing

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

Is 111 (NASDAQ:YI) A Risky Investment?

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Recent updates

111, Inc. Announces Board Changes

111, Inc. to Report Q3, 2024 Results on Nov 28, 2024

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

111, Inc. to Report Q2, 2024 Results on Aug 29, 2024

111, Inc. announced delayed 20-F filing

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Second quarter 2023 earnings released: CN¥0.68 loss per share (vs CN¥1.14 loss in 2Q 2022)

111, Inc. to Report Q2, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: CN¥0.38 loss per share (vs CN¥1.33 loss in 1Q 2022)

111, Inc. to Report Q1, 2023 Results on Jun 15, 2023

Full year 2022 earnings released: CN¥5.00 loss per share (vs CN¥8.08 loss in FY 2021)

Third quarter 2022 earnings released: CN¥1.16 loss per share (vs CN¥3.05 loss in 3Q 2021)

Insufficient new directors

111, Inc. to Report Q3, 2022 Results on Dec 01, 2022

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Second quarter 2022 earnings released

111, Inc. Provides Revenue Guidance

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

111, Inc. to Report Q2, 2022 Results on Aug 25, 2022

111, Inc.'s Inexorable Drive Towards Profitability

First quarter 2022 earnings released

Insufficient new directors

111, Inc. to Report Q1, 2022 Results on Jun 16, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

111, Inc. to Report Q4, 2021 Results on Mar 17, 2022

Third quarter 2021 earnings released

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2021 earnings released

111, Inc. Provides Preliminary Revenue Guidance for the Third Quarter of 2021

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

First quarter 2021 earnings released: CN¥1.77 loss per share (vs CN¥1.52 loss in 1Q 2020)

111, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

Is 111 (NASDAQ:YI) A Risky Investment?

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

111, Inc. Provides Earnings Guidance for the First Quarter of 2021

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

111, Inc. to Report Q4, 2020 Results on Mar 18, 2021

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

New 90-day high: US$12.70

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

New 90-day high: US$7.62

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Third quarter 2020 earnings released: CN¥1.32 loss per share

111 reports Q3 results, provides Q4 revenue guidance

111, Inc.: Cheap But Risky And Controlled By Founders

New 90-day high: US$7.45

111, Inc. Announces Management Changes

111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

New 90-day low - US$5.96

First half earnings released

111, Inc. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day low - US$6.14

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven